Paul Matteis

Stock Analyst at Stifel

(1)
# 2103
Out of 5,345 analysts
139
Total ratings
33.33%
Success rate
-6.03%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
VIGL Vigil Neuroscience
Downgrades: Hold
11 8
7.88 1.52% 2 May 28, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
300 345
288.68 19.51% 13 Mar 31, 2025
NMRA Neumora Therapeutics
Downgrades: Hold
6 2
0.71 181.69% 2 Mar 7, 2025
RYTM Rhythm Pharmaceutica...
Reinstates: Buy
78
59.98 30.04% 1 Mar 5, 2025
SION Sionna Therapeutics
Initiates Coverage On: Buy
32
12.91 147.87% 1 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
4.29 156.41% 1 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 32
12.38 158.48% 2 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
490 494
445.02 11.01% 18 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 32
15.12 111.64% 1 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
10 6
6.54 -8.26% 5 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4
1.42 181.69% 4 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
2.73 266.3% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 60
17.77 237.65% 2 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25 36
30.09 19.64% 7 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
115 87
57.95 50.13% 8 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 66
11.82 458.38% 3 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
9.57 265.73% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 53
33.13 59.98% 5 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 21
22.14 -5.15% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
3.39 755.46% 1 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
141 144
123.31 16.78% 8 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
315 287
127.51 125.08% 6 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
2.8 614.29% 1 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
2.51 378.09% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24
1.51 1489.4% 2 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 295
n/a n/a 4 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
50 54
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
36 5
0.28 1685.71% 2 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 32
11.46 179.23% 1 Jun 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
n/a n/a 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
1.05 2471.43% 1 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 23
n/a n/a 2 Dec 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
150 140
n/a n/a 7 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
9.07 54.36% 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
n/a n/a 6 Nov 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3000 2280
n/a n/a 1 Oct 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
25 31
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 18
n/a n/a 2 Feb 27, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 64
6.12 945.75% 1 Feb 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 22
n/a n/a 2 Oct 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
340
23.07 1373.78% 1 Dec 21, 2016